A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index; 20 of the 36 sources its claims cite were checked for support.
Abstract
Oncogene-induced senescence (OIS) is crucial for tumour suppression. Senescent cells implement a complex pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). The SASP reinforces senescence, activates immune surveillance and paradoxically also has pro-tumorigenic properties. Here, we present evidence that the SASP can also induce paracrine senescence in normal cells both in culture and in human and mouse models of OIS in vivo. Coupling quantitative proteomics with small-molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF-β family ligands, VEGF, CCL2 and CCL20. Amongst them, TGF-β ligands play a major role by regulating p15(INK4b) and p21(CIP1). Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling. The inflammasome and IL-1 signalling are activated in senescent cells and IL-1α expression can reproduce SASP activation, resulting in senescence. Our results demonstrate that the SASP can cause paracrine senescence and impact on tumour suppression and senescence in vivo.
Overview
CoChat Summary
## TL;DR
Cells undergoing oncogene-induced senescence (OIS) can transmit senescence to neighboring normal cells through secreted SASP factors, creating a stable paracrine senescence state in culture and in vivo. The paper identifies TGFβ family ligands and IL-1/inflammasome signaling as key regulators of this process.
## Key findings
- Normal IMR90 fibroblasts and HMECs became growth-arrested when co-cultured with OIS cells; the effect was transmitted through transwells and conditioned media, showing it was mediated by soluble factors rather than direct contact.
- Paracrine senescence resembled full senescence: normal cells showed increased DNA/oxidative damage, p16^INK4a^, p21^CIP1^, and SASP markers; gene-expression profiles of OIS and paracrine senescence were highly correlated and clustered together.
- Quantitative proteomics and a 78-compound screen implicated multiple SASP components in paracrine senescence, including TGFβ family ligands, VEGF, CCL2, and CCL20; blocking VEGFR2/FLT3, TGFBR1, or CCR2 partially impaired the arrest.
- The paper reports specific in vivo evidence of paracrine senescence: p21^CIP1^+/p16^INK4a^ cells were found near OIS lesions in mouse liver and skin, and in human serrated sessile adenomas the stromal p21^CIP1^/Ki-67^- signal was significantly increased near lesions (p = 0.03), with a separate comparison reporting p = 4.6 × 10^-5^ for p21^CIP1^ positive/Ki67 negative stromal cells.
## Methods
- Co-culture, transwell, conditioned-media, and cluster assays were used in human IMR90 fibroblasts and HMECs; OIS was induced with ER:RAS, MEK:ER, or related oncogenic constructs activated by 4OHT.
- Secretome analysis used SILAC-based quantitative proteomics, followed by a 78-compound receptor/pathway screen, RNAi knockdown, RT-qPCR, microarrays, GSEA, immunofluorescence/high-content analysis, and assays for BrdU, SA-β-Gal, caspase-1, and antibody arrays.
- In vivo validation used mouse OIS models including Nras-driven hepatocyte senescence, K5-Sos/Egfr^wa2/+^ skin papillomas, and Pdx1-Cre Kras^G12D^ pancreatic lesions, plus human SSA tissue IHC.
## Limitations
- The paper itself notes that “the nature of these cells and the functional implications of paracrine senescence remain open questions for future studies.”
- It also states that not all cells surrounding preneoplastic lesions undergo paracrine senescence; it proposes possible explanations such as soluble-factor gradients and cell-type susceptibility, but these are not experimentally resolved here.
- Evident from the text: many mechanistic and inhibitor results are partial (“partially rescued,” “partially prevented”), so the study does not identify a single exclusive mediator of paracrine senescence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Valid · 1 Not valid · 7 Not checked · 78 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“a transcriptional signature associated with senescence 18 was significantly upregulated during paracrine senescence (Fig 3d).”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence resembles a full senescence response
What the sources say
- Supportedcites [18] Fridman AL, Tainsky MA. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene. 2008; 27:5975-87. [PubMed: 18711403] source
The 'Genomic approaches to identify senescence/immortalization genes and pathways' section describes gene-expression profiling that identifies genes and pathways associated with senescence. In the citing sentence, the citation identifies the senescence-associated transcriptional signature; the finding that it was significantly upregulated during paracrine senescence is attributed to the citing paper’s Fig. 3d, not to this source. No page number is available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Colon SSAs are mainly driven by activating BRAF mutations that trigger OIS 31,34,35 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence is observed in mouse and human models of OIS in vivo
What the sources say
- Partly supportedcites [31] Carragher LA, et al. V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol Med. 2010; 2:458-71. [PubMed: 20941790] sourceExperimental — accuracy not yet measured
The Discussion reports V600E BRAF mutations in approximately 70% of right-sided serrated hyperplastic polyps and serrated adenomas, supporting a major role for BRAF in the serrated pathway. The Results show that V600E Braf induces senescence in mouse small-intestinal crypts, but do not establish that BRAF mutations trigger OIS in human colon sessile serrated adenomas. (LLM, conf=0.87)
- Partly supportedcites [34] Kriegl L, et al. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/ adenomas indicates a senescence barrier in the serrated route to colon cancer. Modern Pathology. 2011; 24:1015-22. [PubMed: 21423154] sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that initiating BRAF mutations might drive oncogene-induced senescence in human serrated polyps, and concludes that the data provide evidence for senescence in the BRAF-mutated serrated route. It does not establish that colon sessile serrated adenomas are mainly driven by BRAF mutations: the study selected BRAF-mutated lesions for its final analysis, and its proposed causal link is hedged. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [35] Bennecke M, et al. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell. 2010; 18:135-46. [PubMed: 20708155] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A signature derived from IMR90 cells undergoing paracrine senescence is found enriched in mouse PANIN 44 and human serrated sessile adenomas (SSA) 36 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > REFERENCES
What the sources say
- Partly supportedcites [44] Ling J, et al. KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell. 2012; 21:105-20. [PubMed: 22264792] sourceExperimental — accuracy not yet measured
The Results section, “Inhibition of Key Proinflammatory Cytokines,” reports gene-expression profiles from mouse PanIN, so this paper provides the mouse PanIN data cited as reference 44. It does not report testing or finding enrichment of an IMR90 paracrine-senescence signature in those profiles. The SSA finding is attached to a different citation (36), not this source. (LLM, conf=0.79)
- Not checked — no full text of the sourcecites [36] Caruso M, et al. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Archiv. 2009; 454:291-302. [PubMed: 19172291] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
- Also stated in: § Abstract · plain
“Coupling quantitative proteomics with small molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling.”
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
54 more claims
Create a free account to see all 101 claims and every source verdict.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 21
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The senescent cell fate can be triggered by a number of stressors including DNA damage, cancerous mutations or oncogene activation, mitochondrial dysfunction, reactive metabolites, hyperoxia or hypoxia, proteotoxic stress, extracellular signals, infections, mechanical or shear stresses that deform cells, resistance exercise and factors secreted by other senescent cells18,38–47.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The inflammasome, a multiprotein complex comprising caspase 1 and key regulators of the defence mechanisms against pathogens117, and Toll-like receptors, which regulate the inflammasome, have been reported to promote maturation and secretion of SASP factors during OIS73,118.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, specific SASP components, either soluble or in extracellular vesicles186, can induce senescence in a paracrine manner — which includes DDR activation73,83.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upstream signals triggering SASP activation are multiple and differ depending on the senescence inducer but include DNA damage, cytoplasmic chromatin fragments (CCFs) that trigger a type 1 interferon response, and damage-associated molecular patterns (DAMPs) that activate the inflammasome (Acosta et al., 2013; Davalos et al., 2013; Li and Chen, 2018).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher secretion of SASP factors is also associated with an enhanced immune response, leading to inflammation which may promote tumorigenesis (Acosta et al., 2013).”
From Single senescent cell sequencing reveals heterogeneity in senescent cells induced by telomere erosion (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measured
47 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cited by
Items 2,101–2,200 of 2,275
Reduced activin A levels impair urogenital system development and compromise female mouse fertility
Winek, E., Szczepańska, K., Bednarek, M., Wolińska‐Nizioł, L., & Suwińska, A. (2026) · Molecular Human Reproduction · doi:10.1093/molehr/gaag007
“BAP1 Loss Induces Senescence and Enhances the Response to Radiation Therapy and Senolytics”Preprint
Elsayed, A. M., Mosbeh, A., Eltasawi, E. G., Hanpude, P., Uddin, N., Cebulla, C. M., & Abdel‐Rahman, M. H. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.05.704104
“Taken together, these findings may provide evidence that BAP1 loss creates a pro-tumorigenic niche that fosters angiogenesis, stromal remodeling, and immunomodulation [36, 37].”
Wang, X., Lu, M., Jia, S., Zhang, J., Wang, X., Qi, Y., Shi, N., Jiao, Y., Zhao, J., Wang, X., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-38480-0 · Cited by 2
“SASP factors not only lead to the cell cycle arrest 35 , but also cause higher level of inflammatory response 36 , slower healing of wounds 37 and so on.”
Zhang, D., Li, Z., Meng, X., Wang, T., Miao, Z., & Deng, H. (2026) · ACS Omega · doi:10.1021/acsomega.5c09277
Sunaga, M., Yukimori, A., Tanaka, J., Aizawa, R., Okada, K., Saito, D., Mishima, K., & Yamamoto, M. (2026) · Journal of Oral Biosciences · doi:10.1016/j.job.2026.100748
Kikuchi, K., Murakami, Y., Sato, H., Yamashita, R., Saya, Y., Uchino, R., Sugita, T., Shinkai, Y., 高原, 佑., Shingaki, K., et al. (2026) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.70707
“IL-8 is a factor in the senescence-associated secretory phenotype (SASP) and induces cellular senescence [26].”
Systems-level modelling of DNA damage, senescence, and stem cell dynamics in ageing
Che, A., Morgan, A. E., & Auley, M. T. M. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113063
The effect of astrocyte depletion and repopulation approaches in pathological condition of CNS
Tahmasebi, F., Safarian, A., Asl, E. R., Vahidinia, Z., & Barati, S. (2026) · Acta Neurologica Belgica · doi:10.1007/s13760-026-03005-z
Dasatinib and Quercetin Senolytics for Health and Longevity
Salas-Venegas, V., Flores-Torres, R. P., Alarcón‐Aguilar, A., López‐Díazguerrero, N. E., & Königsberg, M. (2026) · Healthy ageing and longevity · doi:10.1007/978-3-032-11608-6_20
Characterizing mitochondrial phenotypes and MERCS in aged human skeletal muscle myoblasts
Unten, Y., Takafuji, K., Masukagami, Y., Shiiba, I., Horiuchi, K., Husník, F., Yanagi, S., Tateishi, N., & Suzuki, T. (2026) · PLoS ONE · doi:10.1371/journal.pone.0343604 · Cited by 3
Manjunath, G. K., Nashier, D., & Kumar, A. (2026) · Archives of Medical Research · doi:10.1016/j.arcmed.2026.103384 · Cited by 1
Cellular Senescence in Human Periodontal Tissue: A Narrative Review
Hasuike, A., Takada, K., Takano, C., Hosono, A., Sato, S., & Komine‐Aizawa, S. (2026) · Oral Diseases · doi:10.1111/odi.70258
“Furthermore, the paracrine release of these factors can induce “secondary se-nescence” in neighboring healthy cells, spatially expanding the lesions (Acosta et al. 2013).”
Liu, H., Lin, X., Dai, L., Zhang, W., Zhang, Y., Liu, N., Li, Y., Peters, J. J., Gu, J., Peng, K., et al. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03681-y · Cited by 1
“SASP, a unique characteristic of senescent cells, can enhance their own senescence through autocrine signaling and also influence the tissue microenvironment by transducing paracrine signals to neighboring tumor cells and non-tumor cells [89–91].”
Microglial senescence and senolytic drugs
Ben-Azu, B., Sabbah, S., Awogbindin, I. O., Chidebe, E. O., Oritsemuelebi, B., Patel, D., Frenkel, D., & Tremblay, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27340-7.00010-3
Lim, S. H., Seo, H. S., Kang, H., & Hong, S.-P. (2026) · Journal of Ginseng Research · doi:10.1016/j.jgr.2026.101018 · Cited by 1
“A key feature of senescent cells is the senescence-associated secretory phenotype (SASP), which involves the secretion of pro-inflammatory cytokines and chemokines [8,9].”
Song, Y., Li, R., & Guo, H. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128430 · Cited by 1
Multifacet Roles of Cellular Senescence in Cancer: Mechanisms and Therapeutic Implications
Mao, H., Liu, W., Su, Y., Ma, Y., Zhao, X., & Lu, Y. (2026) · MedComm – Oncology · doi:10.1002/mog2.70060 · Cited by 1
Parihar, S. S., Tripathi, J., Kundu, S., Banerjee, S. S., Anerao, I., & Sinha, P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.13.711573
“These SASP factors, mainly pro-inflammatory cytokines, can trigger localized and systemic perturbations, for instance, activation of the paracrine (Acosta et al., 2013; Kuilman et al., 2008; Nelson et al., 2012) and, more recently identified, systemic senescence program (Kiourtis et al., 2024).”
Plasminogen Activator Inhibitor 1, Cell Senescence, and Aging-Related Diseases
Liu, R.-M., & Nakamya, M. F. (2026) · Cells · doi:10.3390/cells15060551 · Cited by 1
“OIS cells are characterized by canonical markers such as γ H2AX foci, SA-β -gal activity, and a robust SASP [16,17,134,135].”
InfluentialStem Cells in Aging and Anti-Aging
Bai, Z., & Li, Z. (2026) · Stem Cell Reviews and Reports · doi:10.1007/s12015-026-11093-w
Rôle de la kinase Akt dans la chimiorésistance : Régulation de l’équilibre Apoptose-Sénescence
Vétillard, A. (2015) · theses.fr (ABES) · doi:10.70675/d0db61dazb197z42dczbb98z6f0276f570b6
Modulation de la sénescence induite par les oncogènes par les glucocorticoïdes et rôle de EGR1
Carvalho, C. (2018) · theses.fr (ABES) · doi:10.70675/7cafc6a4za30dz467dz81a1z7033a7846a52
Les cellules sénecentes comme niche de survie : rôle de la voie TSP1-CD47
Moreau, M. (2017) · theses.fr (ABES) · doi:10.70675/e62d69b6z1f00z4f88z817bzda54e624150f
de Jong, D. (2018) · theses.fr (ABES) · doi:10.70675/27595e3bzbf8ez4196zb9b4z036b359e6b5c
Zhang, X., Yang, L., He, X., Zhao, M., Fang, Z., Xu, G., Duan, Z., & Luo, K. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.03.050 · Cited by 2
“These cytokines recruit immune cells to the sites of senescent cells, aiding in immune surveillance and clearance of damaged cells 41,42 .”
de Freitas, J. A. N. L. F. (2020) · theses.fr (ABES) · doi:10.70675/0e6e3614z3915z4fb8za2cdz24b40b9679b2
Lohard, S. (2019) · theses.fr (ABES) · doi:10.70675/10e179e8zfcc6z4481zbb4bzafeef9c41257 · Cited by 1
The role of Activin signaling pathway in the initiation and progression of pancreatic cancer
Zhao, Y. (2019) · theses.fr (ABES) · doi:10.70675/17612dbdz6d94z4563z86a3z6d1e91b34f9b
Tavenier, J., Holm, N. N., Kallemose, T., Houlind, M. B., Andersen, A. L., Hach, L. F., Berglind, M., Andersen, O., Nehlin, J. O., & Rasmussen, L. J. H. (2026) · Aging Cell · doi:10.1111/acel.70469
“This study aims to (1) identify plasma protein signatures showing overlap between older age and elevated disease burden as candidate markers of biological aging; (2) compare these with previously reported age, disease, or SASP-associated proteins to identify previously unrecognized biomarkers of biological aging; and…”
InfluentialGeneration of antisense RNAs at convergent gene loci in cells undergoing senescence
Deb, M. K. (2016) · theses.fr (ABES) · doi:10.70675/739ebf07zf620z4e1fzb0d4z02066589491f
Caractérisation de la sénescence des cardiomyocytes et identification de marqueurs associés
Maggiorani, D. (2017) · theses.fr (ABES) · doi:10.70675/a58747bczd60bz4482za3b2z7ae33d26ffa4 · Cited by 1
“Le TGFβ peut jouer un rôle autocrine et paracrine puisqu’il peut être secrété par les cellules sénescentes et favoriser l’entrée en sénescence des cellules voisines (Acosta et al., 2013).”
InfluentialDissecting the non-cell autonomous impact of cellular senescence on cellular reprogramming
von Joest, M. (2019) · theses.fr (ABES) · doi:10.70675/01382339z05d9z4aacz911dz62afcc7c9191
Implication de GDF15 dans la sénescence et les fonctions des cellules endothéliales.
Ha, G. (2019) · theses.fr (ABES) · doi:10.70675/da2fe5b4z744dz47f9z8aadza1047172fb7c
Impact of aging on cardiac mesenchymal stromal cells
Martini, H. (2019) · theses.fr (ABES) · doi:10.70675/bb7ddcb3z0b6az4c39za6eczc94e0563f0a3
Šrámková, V. (2017) · theses.fr (ABES) · doi:10.70675/ebd7c64ezd314z423cza964z025db5744b2d · Cited by 1
Amélioration de la régénération cellulaire et tissulaire au cours du vieillissement
Alle, Q. (2020) · theses.fr (ABES) · doi:10.70675/932e617bzcb45z4332z8badzfda37d5299a8
Dissecting the impact of cellular senescence on muscle regeneration
Cazin, C. (2020) · theses.fr (ABES) · doi:10.70675/42a7ff38zb338z4eb8za925z2ce0a01ee74e
Millerand, M. (2020) · theses.fr (ABES) · doi:10.70675/d5e9dae6zd9d7z4a05z8fd2zf0ff4ffab0a6
Rôle de l’immunosurveillance des cellules sénescentes dans le cancer et le vieillissement
Iltis, C. (2020) · theses.fr (ABES) · doi:10.70675/9a339b58z5fecz427dz8de4z8ce0bd748478 · Cited by 1
L’échappement à la sénescence induite par chimiothérapie : Un nouveau rôle de la protéine AGR2
Maarouf, A. (2021) · theses.fr (ABES) · doi:10.70675/2804fda4z0d12z4a01za7eezd95a7d0b70d2
The E3 ubiquitin ligase HUWE1 is required for KRAS-induced lung cancer
Searle, J., Menotti, M., McDaid, W. J., Baker, M. J., Chaturvedi, A., GINN, L. H., Reed, H., Carter, M., Blackhall, F. H., Lindsay, C. R., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08672-7 · Cited by 1
Characterization and impact of cellular senescence during mammary gland involution
Charifou, E. (2022) · theses.fr (ABES) · doi:10.70675/54491057z33e4z449fzb26fz6a2e42b1a22e
Mechanisms of precocious ageing in a human progeroid syndrome
Molina, C. F. (2021) · theses.fr (ABES) · doi:10.70675/f78c9fa2z621cz48b6zbf00z1133c36b723a
Control of ependymal cell differentiation by the mTOR signaling pathway
Srivastava, A. (2021) · theses.fr (ABES) · doi:10.70675/0e4dc286zfb40z4d2bza4cdzd6fdff1cc2e8
Caractérisation de nouvelles dépendances oncogéniques dans les hémopathies myéloïdes
Roux, B. (2022) · theses.fr (ABES) · doi:10.70675/d76b6764z8851z423dza26fz9f68e953227e
Intermittent hypoxia induces premature adipose tissue senescence leading to cardiac remodelling
Naushad, S. (2022) · theses.fr (ABES) · doi:10.70675/8490fe58zf0fdz45a9zaa53z703053f519c1
Le rôle de l'histone méthyltransférase SETD2 dans la sénescence
Abdi-Galab, M. (2023) · theses.fr (ABES) · doi:10.70675/d647d7abzc285z4aadza80az4d9bb3925e9e
Rôle de FAT10 dans la sénescence des hépatocytes et le développement de la NASH
Bernard, L. (2023) · theses.fr (ABES) · doi:10.70675/793b0b93z9794z42d4zb8dfz5f3d68268a9b
Bonnefous, H. (2025) · theses.fr (ABES) · doi:10.70675/67742b4az1242z4d30z964ezd8bf9300d4ac · Cited by 1
McFall, D. J., Hussain, A. I., Cho, M., & Forcelli, P. A. (2026) · Epilepsia · doi:10.1002/epi.70226 · Cited by 1
“3,10,11 14 Many factors secreted by SCs are implicated in epileptogenesis.”
Zou, F., Zhu, M., Quan, K., Yu, X., & Li, W. (2026) · International Journal of Surgery · doi:10.1097/js9.0000000000004992
Gupta, K., Swahn, H., & Lotz, M. (2026) · GeroScience · doi:10.1007/s11357-026-02260-5
Loss of sirtuin 3 disrupts cellular senescence signaling pathways
Kura, N., Mogck, B. A., Jezak, S. T., Velarde, M. C., & Wiley, C. D. (2026) · GeroScience · doi:10.1007/s11357-026-02284-x · Cited by 2
“IR-induced senescent cells promoted IL-6 expression in scramble control cells, as in previous studies [23].”
Lyamina, S., Валерьевич, К. С., Kozhevnikova, E. O., & Павловна, Л. Н. (2026) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2026-15-2-122-137 · Cited by 1
The impact of 3D chromatin remodeling on cellular senescence and aging
Chen, W., Zhan, Q., Xiao, F., Ju, Z., & Chen, Z. (2025) · Aging Research · doi:10.26599/agr.2025.9340072
Li, Y. (2024) · Integrate Medicine · doi:10.61958/imsh8177
The unbearable presence of senescent cells in ageing
Kang, C. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-026-00975-x
Dpp and immune response pathway factors mediate paracrine induction of senescent cells in Drosophila
García-Arias, J. M., Ruiz-Losada, M., Azpiazu, N., & Morata, G. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2602167123
Blue period - features of senescence 30 years after beta-galactosidase
Kuehnemann, C., & Wiley, C. D. (2026) · Aging · doi:10.18632/aging.206380
Xie, Q., Lin, T., Jang, S., Jan, C. H., Selahi, A., Nyberg, K. D., Wendorff, A. A., Hake, K., Lefebvre, A. E. Y. T., Jin, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.13.724992
“Because cellular senescence is a hallmark process known to limit cell proliferation in both cell-autonomous and non-cell-autonomous fashion while simultaneously promoting inflammation through the secretion of pro-inflammatory factors 28,41-43 , we hypothesized it might be a driver of this response.”
Mechanistic Insights of Oxidative Stress in Inflammation
Dewangan, J. P., Singh, M., & Shukla, R. (2026) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-032-19837-2_4
Prokopov, A., Дробинцева, А. О., Любякина, П. Н., & Kvetnoy, I. M. (2026) · Успехи геронтологии · doi:10.34922/ae.2026.39s
Shinyashiki, Y., Onodera, Y., Kawashima, Y., Iwawaki, N., Takehara, T., Goto, K., & Teramura, T. (2026) · PLoS ONE · doi:10.1371/journal.pone.0349780
Liu, P., Wang, R., Yu, Y., Ning, Y., Chen, M., & Ye, M. (2026) · Biology Direct · doi:10.21203/rs.3.rs-9810404/v1
Integrating senotherapeutics into transplantation: liver reconditioning in an aging donor pool
Buch, M. L., Esser, H., Perera, H., Zheng, R., Ferreira-González, S., & Forbes, S. J. (2026) · Transplant International · doi:10.3389/ti.2026.16347
“SnCs remain metabolically active and influence the surrounding microenvironment through the secretion of pro-inflammatory cytokines, chemokines, and proteases collectively known as the SASP [69].”
Yasuda, S., Iizumi, Y., Sukeno, M., Sakai, T., & Horinaka, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125199
Tan, S., Huang, X., Li, J., Nepovimová, E., Valko, M., Wu, Q., & Kuča, K. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112208 · Cited by 1
Distinct fibroblast and perivascular senotypes define spatial niches that regulate fibrosisPreprint
Rindone, A. N., Nagaraj, S., Cho, A., Browne, M., Krishnan, K., Adkins, R. S., Lesperance, D., Orvis, J., Daswani, P. S., Mejías, J. C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.08.730636 · Cited by 1
Senescent fibroblasts in aging and pulmonary fibrosis
Palega, S., Borengasser, A. Y., & Sanders, Y. Y. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1816071
Bernardelli, C., Selvaggio, P., Cappello, G., Fede, E. D., Taci, E., Rosa, S., Colombo, E. A., Grazioli, P., Peli, V., Barilani, M., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119556
Molecular mechanisms and recent advances in cellular senescence
Hussain, A., Tatar, M., & Gong, R. (2026) · Cell & Bioscience · doi:10.1186/s13578-026-01596-x · Cited by 4
“TGF-β, chemokines (CCL2, CCL20) and VEGFs are crucial in exerting paracrine effects, whereas ROS signaling through GAP junctions induces senescence in nearby cells commonly referred to as bystander senescence [53, 286, 447].”
Liu, X., Guo, Y., Popa‐Wagner, A., Lämmermann, I., Grillari, J., & Hermann, D. M. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103206 · Cited by 1
Zhang, F., Liao, Y., Yang, P., & Guo, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1850084
Pathological Interplay of ROS With Myofibroblasts: An Impediment to Corneal Restitution
Karimi, M. Y., & Colagar, A. H. (2026) · Oxidative Medicine and Cellular Longevity · doi:10.1155/omcl/5547254
Li, M., Deng, H., Xu, H., Zhou, Q., & Zhao, S. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1842955
An, X., Wu, T., Gou, R., & Fang, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1835582
Renal aging and associated diseases: Common mechanisms and therapeutic approaches
Muhammad, J. A., Julianto, N. M., Setiawan, T., Fadjaray, T. F., Elbert, F., Hussain, M., Wirawan, L. M., Jeong, D., & Kwon, H. Y. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100148 · Cited by 1
Senescent Human Liver Endothelial Cells Mediate CD4 + T Cell Recruitment via ICOSL
Patten, D. A., Lumley, A., Wilkinson, A. L., O'Keeffe, A., Yin, K., Shirgaonkar, N., Gao, R., DasGupta, R., Hoare, M., & Shetty, S. (2026) · Immunology · doi:10.1111/imm.70159
“…of p16 + endothelial cells to other potentially senescent (p16 + ) cells (Figure 1B), we hypothesised that the endothelial cells may be undergoing paracrine senescence, a process in which senescence is transmitted to neighbouring cells via the senescence-associated secretory phenotype (SASP) [14].”
SenoQuant: One-stop AI software for senescence marker analysis and predictionPreprint
Lagnado, A. B., Li, Y., Nwakama, C., Franco, A. C., Han, Y., Jurk, D., Martini, H., Victorelli, S. G., Lee, G., Saul, D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.18.733222
Chen, X., Liu, H., Shu, Q., Tang, Y., Zhang, J., Yu, W., & Li, S. (2026) · Cells · doi:10.3390/cells15121123
“Furthermore, SASP can induce paracrine senescence in neighboring cells, thereby propagating the senescence response within local tissues and limiting the proliferation of potentially aberrant cells, ultimately forming a tissue-level antitumor barrier [93].”
The multifaceted inducers of cellular senescence
Gal, H., & Krizhanovsky, V. (2026) · Aging · doi:10.18632/aging.206391
“Through these factors, SASP secretion amplifies inflammation, further inducing senescence in a self-reinforcing cycle [15].”
InfluentialDihydromyricetin alleviates immunosenescence by modulating the TAK1/MAP3K7 Axis
Duan, H., Li, D. D., Shi, X., Wang, S., Zhang, B., Hu, Z., Zhou, Y., Tong, X., Guo, Y., Huang, T., et al. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113215
Quercetin Mitigates Oxidative Stress-Induced Premature Senescence in SH-SY5Y Neuronal-like Cells
Salamone, F. L., Molonia, M. S., Trischitta, S., Saija, A., Cimino, F., & Speciale, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135759 · Cited by 4
Smoking accelerates immunosenescence in multiple sclerosis
Khan, M., Uawithya, E., Mytych, J. S., Muwenda, I., Reidy, M., Axtell, R. C., & Mao‐Draayer, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1840928
Bhavya, R., & Sandur, R. (2026) · Immunological Investigations · doi:10.1080/08820139.2026.2695165 · Cited by 2
Metadata
- Authors
- Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., Pascual, G., Morris, K. J., Khan, S., Jin, H., Dharmalingam, G., Snijders, A. P., Carroll, T., Capper, D., Pritchard, C., Inman, G. J., Longerich, T., Sansom, O. J., Benitah, S. A., Zender, L., & Gil, J.
- Affiliations
- Imperial College London (GB)
- Centre for Genomic Regulation (ES)
- Cancer Research UK Scotland Institute (GB)
- University of Tübingen (DE)
- German Cancer Research Center (DE)
- University of Leicester (GB)
- University of Dundee (GB)
- Corresponding author
- Gil, Jesús
- ORCID
- Acosta, Juan Carlos
- Banito, Ana
- Janich, Peggy
- Morton, Jennifer P.
- Athineos, Dimitris
- Lasitschka, Felix
- Andrulis, Mindaugas
- Pascual, Gloria
- Khan, Sadaf
- Jin, Hong
- Snijders, Ambrosius P.
- Carroll, Thomas
- Capper, David
- Pritchard, Catrin
- Inman, Gareth J.
- Longerich, Thomas
- Sansom, Owen J.
- Benitah, Salvador Aznar
- Zender, Lars
- Gil, Jesús
- Venue
- Nature Cell Biology
- Published
- 2013-06-16
- Volume
- 15
- Issue
- 8
- Pages
- 978-990
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC3732483
- OpenAlex
- W2140930678
- Semantic Scholar
- 59786bed7ce43f9317328cd82838f14d911e5dd4
- Cited by
- 2,278
- References
- 54
- Citations by year
- 2026: 247 · 2025: 225 · 2024: 232 · 2023: 240 · 2022: 264 · 2021: 250 · 2020: 202 · 2019: 154 · 2018: 119 · 2017: 107 · 2016: 89 · 2015: 79 · 2014: 56 · 2013: 13
- FWCI
- 54.88
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-28)
- Open access
- green
- europepmc.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- NERC Open Research Archive (Natural Environment Research Council) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Cancer Research UK (A7769, 13083, 11650, 12481)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- oncogene-induced senescence, senescence-associated secretory phenotype, paracrine senescence, inflammasome, IL-1 signaling, TGF-beta ligands, vascular endothelial growth factor, MCP-1, CCL20, CDKN2B, p21, tumor suppression, senescence-associated secretome
- MeSH terms
- Animals, Colonic Neoplasms, Humans, Immunohistochemistry, Interleukin-1, Protein Binding, Signal Transduction, Gene Expression Regulation, Neoplastic, Cellular Senescence, Paracrine Communication, Models, Animal, Cell Line, Tumor, Mice, Transforming Growth Factor beta1, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.